Affordable Access

Publisher Website

Therapeutic PD-1 pathway blockade augments with other modalities of immunotherapy T-cell function to prevent immune decline in ovarian cancer.

Authors
Type
Published Article
Journal
Cancer Research
1538-7445
Publisher
American Association for Cancer Research
Publication Date
Volume
73
Issue
23
Pages
6900–6912
Identifiers
DOI: 10.1158/0008-5472.CAN-13-1550
PMID: 23975756
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments